Table 1 Clinical variables of serous ovarian cancer patients in the study
| Â | Patient | Healthy volunteers | |
|---|---|---|---|
|  | (n = 28) | (n = 28) | |
Age (years) | Â | Â | |
   Median | 63 ± 11 | 64 ± 12 | |
   Minimum | 30 | 30 | |
   Maximum | 77 | 79 | |
Histological Grade | Â | Â | |
   Moderately differentiated | 11 |  | |
   Poorly differentiated | 11 |  | |
   Well-differentiated | 1 |  | |
   Unknown | 5 |  | |
Site | Â | Â | |
   Tubal | 3 |  | |
   Peritoneal | 4 |  | |
   Ovary | 20 |  | |
   Endometrial | 1 |  | |
FIGO Stage | Â | Â | |
   4 | 6 |  | |
   4B | 1 |  | |
   3C | 17 |  | |
   3B | 3 |  | |
   2C | 1 |  | |
CA-125 Result | Â | Â | |
   Yes | 19 |  | |
   No | 9 |  | |
BRCA1/2 mutation | Â | Â | |
   Yes | 3 |  | |
   Unknown | 24 |  | |
   No | 1 |  | |
Post Menopausal | Â | Â | |
   Yes | 23 |  | |
   No | 2 |  | |
   Unknown | 2 |  | |
Pre-operative Chemotherapy | Â | Â | |
   Yes | 9 |  | |
   No | 19 |  | |
Prior cancer | Â | Â | |
   Yes | 2 (breast, Craniopharyngioma) | ||
   No | 26 |  | |
Tumour Size | Â | Â | |
   mean | 59.3 ± 33.6 |  | |
   min | 20 |  | |
   max | 140 |  | |
Degree of cytoreduction | Â | Â | |
   < 2 cm | 8 |  | |
   > 2 cm | 8 |  | |
   No Macroscopic | 13 |  | |
   Unknown | 1 |  | |
Survival Statistics | Â | Â | |
   Dead of disease | 12 |  | |
   Recurred | 12 |  | |
   No evidence of disease | 4 |  | |